In this study, the inpatient mortality rate for all under-five admissions was 14.8%. This rate is disproportionately high compared to those observed in studies done in Iran and South Sudan, whose mortality rates were 1.35% and 5.7%, respectively [20, 21]. The higher incidence of mortality in the present study could be attributed to several factors, including inadequate case management, late presentation, delayed initiation of care and treatment, inadequate staffing, and a lack of essential medical supplies.
Our study revealed that SAM children had a longer median time to death (5 days) as compared to non-SAM children (1 day). The possible justification for this could be the fact that non-SAM children had a higher caseload surge compared to SAM children. According to a study done in Iran, a higher caseload surge causes the incorrect allocation of patients to bays where nurses and clinicians are less familiar with the patient’s condition and less likely to detect early danger signs [22]. In this study, we suggested that life-threatening danger signs were detected and managed earlier among SAM children as compared to non-SAM children. This prevented early deaths in SAM, and therefore a longer time to death among SAM children as compared to non-SAM children.
Gender is a potential predictor of mortality in children with SAM. A previous study done in Ethiopia found that male children with SAM had an increased risk of death compared to females [23]. Evidence has shown that males are biologically weaker than females and therefore more susceptible to life’s risks, including death [24]. However, the present analysis showed that gender was not a predictor of mortality for both SAM and non-SAM patients (AHR: 1.67 (95% CI: 0.56–4.91) vs. AHR: 0.74 (95% CI: 0.39–1.40)). The possible causes of this variation could be differences in sample size, study setting, or the severity of the disease.
In line with other studies, our study showed that age was not a predictor of mortality for SAM and non-SAM children (AHR: 1.16 (95% CI: 0.25–4.27) vs. AHR: 1.21 (95% CI: 0.26–5.60)). This is inconsistent with studies done in Egypt [25] and Ethiopia [26] where age was a significant predictor of mortality. According to an Ethiopian study, children who were < 24 months old were 2.8 times more likely to die compared to those > 24 months (AHR:2.84 (95% CI: 1.10–7.73)) [26]. Literature has shown that infants possess weak and underdeveloped immune systems and are therefore more vulnerable to serious diseases and deaths [27, 28].
The predictive effect of breastfeeding on mortality among children with SAM has been reported in several sub-Saharan studies [29, 24]. In a study done in Ethiopia, the findings showed that hospitalized children with SAM who were breastfed were 59% less likely to die compared to non-breastfed children (AHR: 0.41 (95% CI: 0.29–2.37)) [24]. In the present study, our results showed that breastfed children with SAM were 43% less likely to die than their non-breastfed counterparts (AHR: 0.57 (95% CI: 0.14–2.36)). This differs from non-SAM children, where breastfeeding increased the risk of death by 1.24 folds (AHR: 1.24; 95% CI: 0.27–5.69). However, both of these results were not statistically significant.
The association between HIV infection and mortality in SAM has been reported in several studies [29, 30]. Meanwhile, research has aligned this association with nutritional acquired immune deficiency syndrome, which worsens the fragility of a deteriorating immune system [31]. According to a study done in Malawi, HIV-infected children with SAM are three times more likely to die as compared to HIV-negative children [30]. However, the present study showed that HIV was not a significant predictor of mortality for SAM and non-SAM children. The possible causes of this difference could be differences in the study setting, patient management, or sample size.
Consistent with other studies [35, 36], our study showed that shock was significantly associated with mortality among SAM and non-SAM children. In the present study, SAM children with shock had a 15.3-fold increased hazard of death than those without shock (AHR: 15.37 (95% CI: 2.08–113.4)). Among non-SAM children, having shock increased the risk of death by 2.3 folds (AHR: 2.33 (95% CI: 1.18–4.60)). This might be caused by a reduction in the amount of blood transported to different parts of the body, including vital organs, hence causing multi-organ failure [37]. Therefore, we suggested that nurses and clinicians should always assess the signs of shock in sick children and provide appropriate management in accordance with treatment guidelines.
It is scientifically known that antibiotics, including amoxicillin, reduce mortality in children with SAM [32]. This study also observed that children who did not receive amoxicillin had an increased risk of death. SAM children who did not receive amoxicillin had a 4.15 increased hazard of dying compared to those who received amoxicillin (AHR: 4.15 (95% CI: 1.24–13.90)). Among the non-SAM children, those who did not receive amoxicillin had a 20.78 times increased hazard of mortality compared to those who did (AHR: 20.78; 95% CI: 2.81–153.67). The possible reason to explain this could be the fact that amoxicillin, just like any other antibiotic, improves the clinical response to life-threatening infections, therefore reducing the risk of mortality [33, 34].
Contrary to the results observed among SAM children, having received oxygen therapy was a predictor of time to death among non-SAM children. Our study showed that non-SAM children who received oxygen therapy were 3.1 times more likely to die than those patients who had not received oxygen therapy (AHR: 3.17 (95% CI: 1.66–6.05)). This could be attributed to the fact that patients were placed on oxygen therapy in critical situations. This could also be attributed to excessive oxygen supplementation, which caused oxygen toxicity, which led to multiorgan failure [38, 39]. A similar relationship was found in a study done in the United States of America where oxygen therapy was associated with increased inpatient mortality in children because of hyperoxia [40]. To avoid oxygen toxicity, our study suggested that nurses and clinicians should use oxygen therapy with greater caution, particularly on critically ill children.